Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies
Clinical trial NCT04521413 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04521413
- Sponsor
- Treadwell Therapeutics, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2025-11-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.